Related Experiment Video
Updated: Jun 1, 2025
09:16
Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System
Published on: November 8, 2017
10.0K
Current approaches in CRISPR-Cas systems for diabetes.
Vishnu Kirthi Arivarasan1, Diksha Diwakar1, Neethu Kamarudheen2
1Department of Microbiology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, Punjab, India.
Progress in Molecular Biology and Translational Science
|January 17, 2025
Summary
Genetic and molecular insights are crucial for understanding diabetes mellitus (DM). CRISPR genome editing offers revolutionary potential for DM therapies, including correcting mutations and enhancing insulin production.
Area of Science:
- Genetics
- Molecular Biology
- Biotechnology
Background:
- Diabetes Mellitus (DM) remains a significant global health challenge despite medical advancements.
- Understanding the genetic and molecular basis of DM is key to developing new treatments.
Purpose of the Study:
- To explore recent advancements in the genetic and molecular underpinnings of DM.
- To highlight the potential of CRISPR-based genome editing technologies for DM treatment.
Main Methods:
- Review of genetic screening and susceptibility gene identification for early DM diagnosis.
- Exploration of CRISPR-Cas9 applications for DM, including mutation correction and insulin enhancement.
- Analysis of CRISPR delivery methods (viral, non-viral vectors, nanocarriers).
Main Results:
- Improved genetic screening aids in early DM diagnosis and risk stratification.
- CRISPR-Cas9 shows potential for correcting Type 1 DM mutations and enhancing insulin production in Type 2 DM.
- Various delivery methods are being explored for effective CRISPR targeting.
Conclusions:
- Genetic and molecular insights, combined with CRISPR technology, offer promising avenues for potential DM cures.
- Challenges include off-target effects, long-term efficacy, safety, and ethical considerations of genome modification.
Related Concept Videos
01:59CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
02:53CRISPR and crRNAs
16.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.6K
00:49What is Genetic Engineering?
73.5K
Overview
73.5K
02:31Homologous Recombination
50.1K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.1K